Antiretroviral Therapy Perspective

• Paxlovid Rebound: What Is Happening?   Dr Paul Auwaerter discusses Paxlovid rebound and the use of investigational drugs.
  Medscape Infectious Diseases, May 13, 2022
• New HIV PrEP Guidelines This update gives healthcare providers the latest guidance on prescribing HIV pre-exposure prophylaxis (PrEP) -- a powerful tool for HIV prevention -- to their patients.
  CDC Expert Commentary, May 11, 2022
• Episode 4: Retention and Care for Patients With HIV   Drs Michael Saag and Michael Mugavero discuss the connection between antiretroviral therapy, retention, and care for patients with HIV.
  Medscape, May 04, 2022
• Paxlovid Is Here: A Pharmacist's Prescribing Pearls An effective oral medication for COVID-19 is now available. Michael Ganio, PharmD, offers tips on how to prescribe it safely, where to find it in your area, and how it works with the Test to Treat program.
  Medscape Family Medicine, May 03, 2022
• Episode 2: Frontline Therapy for Multiple Myeloma   Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients.
  Medscape, May 03, 2022
• Episode 3: Antiretroviral Therapy, Maintenance, and Switching   Drs Michael Saag and Constance Benson discuss antiretroviral therapy, maintenance, and switching.
  Medscape, April 06, 2022
• To Prevent Future Variants, We Must Protect Those Most at Risk Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
  Undark, March 17, 2022
• Episode 2: HIV Testing and Linkage to Care   Dr Michael Saag and Dr Aadia Rana discuss best practices that providers can implement to prevent the spread of HIV in their local communities and connect HIV-positive patients to lifesaving care.
  Medscape, March 01, 2022
• Episode 1: HIV Treatment: How Our Past Informs Our Present   Drs Michael Saag and Paul Volberding kick off this HIV series by exploring major clinical breakthroughs in the history of HIV treatment.
  Medscape, March 01, 2022
• CROI 2022 Read clinically focused news coverage of key developments from CROI 2022
  Medscape HIV/AIDS, February 15, 2022
• Should We Be Gatekeeping Repurposed Drug Discussions? Mentioning ivermectin's many demonstrated properties is not yelling "Fire!" in a crowded theater.
  Medscape Blogs, January 19, 2022
• "What do I do now?": How a Single Question Shaped a Clinician's Approach to HIV Patient Care   Gregory Huhn, MD, learns to "think slow" and have meaningful conversations with patients to fully understand what they need in order to deal with a new diagnosis of HIV.
  Medscape, December 17, 2021
• Advice on HIV Treatment for Colleagues Early in Their Career: Protect the Patient   Dr Greg Huhn advises clinicians just starting out in the field of HIV treatment to focus on one principle: "How can I best protect my patient?"
  Medscape, December 15, 2021
• Mandrola's Top 10 Cardiology Stories of 2021 Obesity drugs had a good year, the SGLT2 inhibitors stalled, and Entresto looks less impressive -- these are some of the takes from John Mandrola, MD, in his annual review of cardiology research.
  theheart.org on Medscape, December 15, 2021
• The Most Wonderful Time of the Year? Not to All A psychiatrist's advice for overcoming the holiday blues.
  Medscape Blogs, December 07, 2021
• USCHA 2021 Read clinically focused news coverage of key developments from USCHA 2021.
  Medscape HIV/AIDS, December 02, 2021
• Tips to Reduce Treatment Downtime in Lung Cancer   Dr Mark Kris discusses waiting in the oncology setting, focusing on the importance of communication with colleagues and with patients.
  Medscape Oncology, November 29, 2021
• Psoriatic Arthritis Highlights From ACR 2021   Dr Christopher Ritchlin discusses key reports on psoriatic arthritis from ACR 2021, including results of a brepocitinib efficacy study and data on risk factors for progression and patient concerns.
  Medscape, November 24, 2021
• Treatment Tips for Challenging EGFR-Mutant Lung Cancers   Dr Mark Kris discusses challenges related to treating lung cancers with EGFR mutations.
  Medscape Oncology, November 23, 2021
• Are SSRIs a New Weapon in the COVID Fight?   Is there a class effect of SSRIs on mortality in COVID? F. Perry Wilson comments on a new study.
  Medscape, November 16, 2021